间歇性禁食治疗糖尿病:临床实践指南更新时机已到
本文综述了间歇性禁食在糖尿病及糖尿病前期患者中的临床试验证据,指出在2型糖尿病成人中,间歇性禁食可降低HbA1c、空腹血糖、24小时血糖和体重,且与热量限制同样有效,低血糖风险不增加。作者认为证据已足够成熟,应将间歇性禁食纳入临床实践指南作为2型糖尿病的循证生活方式选择之一。
要点
- 间歇性禁食改善血糖控制的效果与热量限制相当,调整药物后不增加低血糖风险。
- 证据尚不足以推荐1型或妊娠期糖尿病患者使用间歇性禁食。
核心结论
- 间歇性禁食治疗2型糖尿病的证据已足够成熟,应纳入临床实践指南作为循证生活方式选项之一。
研究设计与样本
- 个人观点文章,综合了超过225项临床试验的证据,其中近40项在糖尿病或糖尿病前期患者中开展。
主要发现
- 间歇性禁食改善血糖控制的效果与热量限制相当,按简单规则调整药物后不增加低血糖风险。
- 间歇性禁食可能降低糖尿病前期成人的血糖,但1型或妊娠期糖尿病数据不足。
关键数值与推荐
- 美国糖尿病协会(ADA)诊疗标准和国际糖尿病联盟(IDF)全球临床实践推荐尚未推荐间歇性禁食。
- 间歇性禁食是美国第三种最常实践的饮食方式。
临床怎么用
- 临床医生可将间歇性禁食作为2型糖尿病的循证生活方式选项之一,并按简单规则调整药物以安全实施。
局限性
- 1型糖尿病和妊娠期糖尿病数据不足,无法推荐间歇性禁食。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intermittent fasting is now the third most commonly practiced diet in the USA. Yet, despite more than 225 clinical trials-including nearly 40 in patients with diabetes or prediabetes-intermittent fasting has not yet been recommended as part of the American Diabetes Association (ADA) Standards of Care or the International Diabetes Federation (IDF) Global Clinical Practice Recommendations. In this Personal View, we start by synthesising evidence from trials in patients with type 2 diabetes, type 1 diabetes, prediabetes, and gestational diabetes. In adults with type 2 diabetes, diverse types of intermittent fasting, such as time-restricted eating, the 5:2 diet, and the fasting mimicking diet, reduce HbA1c (typically by 0·3-1·2%), fasting glucose, 24-h glucose, and bodyweight relative to usual eating patterns. Moreover, intermittent fasting is as effective as calorie restriction for improving glycaemic control and does not increase the risk of hypoglycaemia when medications are adjusted using simple rules. Intermittent fasting might also reduce glycaemia in adults with prediabetes, whereas there are insufficient data to recommend its use in people with type 1 or gestational diabetes. Therefore, we argue that the evidence base has sufficiently matured to warrant including intermittent fasting in clinical practice guidelines as one of several evidence-based lifestyle options for type 2 diabetes. We also provide practical guidance for clinicians on prescribing intermittent fasting and safely managing people with diabetes.
引用
- Varady KA, Chow LS, Peterson CM, et al. Intermittent fasting to treat diabetes: time to update clinical practice guidelines. Lancet Diabetes Endocrinol. 2026. PMID: 42361830. doi:10.1016/S2213-8587(26)00119-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。